ArticleFrontiers in microbiology2018
Carbapenem-Resistant
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 33 citations in OpenAlex.
- The healthy human gut as a covert reservoir for mobile antimicrobial resistance: nationwide genomic surveillance of Enterobacter cloacae complex in China.BMC microbiology · 2026Article
- Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance inFrontiers in cellular and infection microbiology · 2025Article
- Dissemination and characteristics of carbapenem-resistantFrontiers in microbiology · 2023Article
- Co-occurrence of dual carbapenemases KPC-2 and OXA-48 with the mobile colistin resistance geneFrontiers in cellular and infection microbiology · 2022Article
- Novel insights related to the rise of KPC-producingFrontiers in cellular and infection microbiology · 2022Article
- Molecular characterization of NDM-1-producing carbapenem-resistantFrontiers in cellular and infection microbiology · 2022Article
- Bloodstream Infections caused by Klebsiella pneumoniae and Serratia marcescens isolates co-harboring NDM-1 and KPC-2.Annals of clinical microbiology and antimicrobials · 2021Article
- Carbapenem-ResistantInfection and drug resistance · 2021Article
- Emerging Threat of Multidrug Resistant Pathogens From Neonatal Sepsis.Frontiers in cellular and infection microbiology · 2021Article
- Novel Carbapenem-ResistantInfection and drug resistance · 2020Article
- Carbapenem-ResistantInfection and drug resistance · 2020Article
- Emergence of NDM-5-ProducingFrontiers in microbiology · 2020Article
- Characterization of a New Transposon, TnFrontiers in microbiology · 2020Article
- NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.Clinical microbiology reviews · 2019Review
- High Prevalence of Metallo-β-Lactamase-ProducingFrontiers in microbiology · 2019Article
- Emergence of New Delhi Metallo-Beta-Lactamase (NDM) andBioMed research international · 2019Article
- Detection and characterization of tigecycline heteroresistance in E. cloacae: clinical and microbiological findings.Emerging microbes & infections · 2019Article
- Epidemiology of and risk factors for infection with extended-spectrum β-lactamase-producing carbapenem-resistant Enterobacteriaceae: results of a double case-control study.Infection and drug resistance · 2018Article
- Prevalence of extensive drug resistance in bacterial isolates harboringPakistan journal of medical sciencesArticle
Corrections and comments
- Erratum issued
Authors and funding
12 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Carbapenem-resistant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.